FDA Guidance for Industry Considerations for Plasmid DNA Vaccines for Infectious Disease Indications
Title:
FDA Guidance for Industry
Considerations for Plasmid DNA Vaccines for Infectious Disease Indications
Origin/Publisher:
Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091968.pdf
Document Type:
Guidance for Industry
Content:
This guidance describes our current recommendations concerning preclinical development and testing of DNA vaccines to prevent infectious diseases. This guidance supercedes the 1996 Points to Consider document. In addition, this guidance finalizes the draft guidance of the same title dated February 2005.